Promoter holding
64.27%
AB
Ajay Bio-Tech (India) Limited - Due diligence report
A 360° intelligence report on Ajay Bio-Tech (India) Limited: trust score, financial health, credit view, compliance, directors, growth and d…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Ajay Bio-Tech (India) Limited — 360° Intelligence Report
Generated from MCA filings & public records66/100
Trust Score
Moderate
Ajay Bio-Tech (India) Limited is assessed as Moderate with a Trust Score of 66/100. Ajay Bio-Tech (India) Limited is an active public limited indian non-government company incorporated in 1990, operating in the Life Sciences sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 10 Aug 2026 from the latest processed filings. Ajay Bio-Tech (India) Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
66/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
51/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Negative operating earnings - debt service depends on external support.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 2 open (35.40 cr) · 13 satisfied (12.66 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 2 | 48.0 cr |
| Others | 8 | 48.0 cr |
| Idbi Bank Limited | 1 | 48.0 cr |
| Vidya Sahakari Bank Limited | 1 | 48.0 cr |
| Technology Dev. Board | 1 | 48.0 cr |
| Industrial Dev. Bank Of India | 2 | 48.0 cr |
Compliance Score: 51/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Flagged by authority: MCA.
- Litigation present in 1 court forum(s).
- 15 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SUJIT SOHANLAL JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHANDRAMAULI BALAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY MALPANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DHANALAKSHMI SRIRAMAPRASAD | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUBRATA SARKAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 5 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
0 allotment(s) · 7 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Netsurf Bio-tech Private Limited | Associate Company | 74.00% |
Key managerial personnel: SUJIT SOHANLAL JAIN (Managing Director) · SUBRATA SARKAR (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 60 · Distress 60
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Operating for 36+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Compliance score is weak (51/100).
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence58/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment52/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 35.40 cr already registered.
- Compliance gaps should be priced into terms.
Investor view58/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
19 Jan 2024
Charge satisfied
Others
28 Mar 2023
Director ceased
CHANDRAMAULI BALAN
27 Mar 2023
Charge satisfied
Others
21 Jan 2023
Director appointed
CHANDRAMAULI BALAN (Director)
13 Jun 2022
Charge created
Others - 83,363.00
02 May 2022
Charge created
Others - 1.44 Lakh
12 Apr 2022
Charge created
Others - 39.63 Lakh
08 Apr 2022
Charge created
Others - 1.20 Lakh
06 Dec 2021
Charge created
Hdfc Bank Limited - 17.70 cr
03 Sep 2021
Charge created
Hdfc Bank Limited - 17.70 cr
16 Apr 2021
Charge created
Others - 12.00 Lakh
07 Apr 2021
Charge created
Others - 45.69 Lakh
31 Mar 2019
Share transfer (FY 2019)
5200.00000000 shares to Sanjay Goverdhandas Malpani
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
5 active director(s) / partner(s); board looks stable and experienced.
15 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Unidrug Innovative Pharma Technologies Limited | U85120MP1987PLC003875 | Indore, Madhya Pradesh, India |
| Omega Colors Private Limited | U24221MH2002PTC137219 | Mumbai, Maharashtra, India |
| Unimax Chemicals Private Limited | U24239MH1985PTC036332 | Thane, Maharashtra, India |
| Mohan Polyfab Pvt Ltd | U17120GJ1985PTC008194 | Ahmadabad City, Gujarat, India |
| Shreenath Fine Chem (India) Private Limited | U51900MH1999PTC119786 | Nagpur, Maharashtra, India |
| Arco Life Sciences (India) Private Limited | U24230MH2003PTC142101 | Nagpur, Maharashtra, India |
| Romit Resins Private Limited | U25209MH1980PTC023375 | Panvel, Maharashtra, India |
| Yantra Fintech | U65993TN2005PLC055804 | Chennai, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Ajay Bio-Tech (India) Limited before audits and certifications: compliance score 51/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Ajay Bio-Tech (India) Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Ajay Bio-Tech (India) Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 66/100, distress signals and MSME payment-delay disclosures - know whether Ajay Bio-Tech (India) Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Ajay Bio-Tech (India) Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Ajay Bio-Tech (India) Limited an active company?
Ajay Bio-Tech (India) Limited has MCA status “Active” with a compliance score of 51/100 (Moderate).
Is Ajay Bio-Tech (India) Limited financially healthy?
Ajay Bio-Tech (India) Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.
Should I do business with Ajay Bio-Tech (India) Limited?
Its overall Trust Score is 66/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Ajay Bio-Tech (India) Limited?
Promoters hold a minority stake - exact percentages are in the full report. 5 active director(s) are on record.
Does Ajay Bio-Tech (India) Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 13 earlier charge(s) stand satisfied.
Is Ajay Bio-Tech (India) Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 51/100 (Moderate).
Is it risky to lend to Ajay Bio-Tech (India) Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
